Comparison
Why is Nxera Pharma Co., Ltd. ?
- NET SALES(HY) At JPY 14,521 MM has Grown at -9.89%
- ROCE(HY) Lowest at -19.35%
- CASH AND EQV(HY) Lowest at JPY 48,826 MM
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -8.47%, its profits have risen by 73.4%
- Along with generating -8.47% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Nxera Pharma Co., Ltd. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at JPY -2,668 MM
Fallen by -6.8% (YoY
At JPY 14,521 MM has Grown at -9.89%
Lowest at -19.35%
Lowest at JPY 48,826 MM
Highest at 60.68 %
Lowest at 0.81 times
Highest at JPY 5,764 MM
Lowest at JPY -8,112 MM
Lowest at JPY -7,721 MM
Lowest at JPY -85.48
Here's what is working for Nxera Pharma Co., Ltd.
Operating Cash Flows (JPY MM)
Raw Material Cost as a percentage of Sales
Here's what is not working for Nxera Pharma Co., Ltd.
Pre-Tax Profit (JPY MM)
Net Profit (JPY MM)
Interest Paid (JPY MM)
Net Sales (JPY MM)
Interest Paid (JPY MM)
Pre-Tax Profit (JPY MM)
Net Profit (JPY MM)
EPS (JPY)
Cash and Cash Equivalents
Debt-Equity Ratio
Inventory Turnover Ratio






